Active, Not Recruiting
A Study to Learn About the Safety of PREVENAR 20 Vaccine in Infants Aged Between Two to Six Months
NCT06622109
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
- Locations
-
- Pfizer Tokyo, Japan